AtriCure Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
81,889.00
107,454.00
129,088.00
155,109.00
174,716.00
201,630
Cost of Goods Sold (COGS) incl. D&A
22,326.00
31,704.00
36,880.00
44,008.00
48,553.00
54,510
Gross Income
59,563.00
75,750.00
92,208.00
111,101.00
126,163.00
147,120
SG&A Expense
69,247.00
84,078.00
117,106.00
141,270.00
147,064.00
153,422
EBIT
9,684.00
8,328.00
24,231.00
30,169.00
20,901.00
6,302
Unusual Expense
935.00
8,215.00
2,546.00
969.00
4,078.00
10,825
Non Operating Income/Expense
275.00
574.00
297.00
586.00
138.00
183
Interest Expense
566.00
305.00
292.00
1,801.00
2,264.00
4,607
Pretax Income
11,444.00
16,178.00
27,176.00
33,298.00
26,878.00
20,911
Income Tax
18.00
33.00
36.00
40.00
14.00
226
Consolidated Net Income
11,462.00
16,211.00
27,212.00
33,338.00
26,892.00
21,137
Net Income
11,462.00
16,211.00
27,212.00
33,338.00
26,892.00
21,137
Net Income After Extraordinaries
11,462.00
16,211.00
27,212.00
33,338.00
26,892.00
21,137
Net Income Available to Common
11,462.00
16,211.00
27,212.00
33,338.00
26,892.00
21,137
EPS (Basic)
0.56
0.61
0.97
1.05
0.83
0.62
Basic Shares Outstanding
20,431.00
26,374.00
28,058.00
31,609.00
32,387.00
34,087
EPS (Diluted)
0.56
0.61
0.97
1.05
0.83
0.62
Diluted Shares Outstanding
20,431.00
26,374.00
28,058.00
31,609.00
32,387.00
34,087
EBITDA
7,664.00
3,554.00
17,953.00
20,870.00
11,773.00
2,452
Other Operating Expense
-
-
667.00
-
-
-
Non-Operating Interest Income
16.00
96.00
190.00
227.00
227.00
1,006

About AtriCure

View Profile
Address
7555 Innovation Way
Mason Ohio 45069
United States
Employees -
Website http://www.atricure.com
Updated 07/08/2019
AtriCure, Inc. engages provision of treatment of atrial fibrillation and left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures.